Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
ADH5	"ADH-3, ADHX, FDH, GSNOR"	ENSG00000197894	"Alcohol dehydrogenase 5 (class III), chi polypeptide"	P11766	4	99070978-99088801	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044578, HPA061919"	Approved					NA	NA		6800000			"HPA044578: AB_2679002, HPA061919: AB_2684638"	"unprognostic (1.05e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.14e-3)"	"prognostic favorable (9.90e-5)"	"unprognostic (2.63e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.48e-2)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (4.58e-10)"	"unprognostic (1.79e-3)"	"unprognostic (9.05e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-1)"	35.6	19.8	17.3	18.5	18.5	6.3	28.6	11.2	22.3	34.1	39.4	19.8	17.0	24.9	53.8	40.3	43.5	28.6	20.8	31.9	13.7	16.6	46.6	69.7	19.9	15.3	15.7	16.1	39.1	12.8	10.5	15.1	19.9	18.6	45.0	27.7	28.7	17.3	35.9	20.7	13.8	28.5	43.6	13.5	20.5	27.0	27.2	10.0	35.2	30.4	18.4	18.6	60.0	22.0	13.9	12.5	18.2	11.1	26.2	25.3	17.0	15.9	13.0	38.6	21.7	70.2	65.3	23.2	26.6	46.9	28.9	25.3	14.9	19.0	18.5	15.5	38.4	18.6	13.6	26.5	36.9	27.9	13.3	11.1	12.8	17.7	58.6	68.0	22.3	10.4	58.7	28.7	21.6	17.1	30.2	22.2	19.5	23.6	10.6	38.0	18.1	30.0	20.1	31.0	3.9	15.7	22.0	21.6	9.7	45.6	18.7	14.8	19.4	16.0	19.0	29.0	29.6	15.4	15.7	16.6	26.4	16.7	17.2	18.2	11.1	13.8	25.6	27.0	14.8	26.7	9.8	11.1	18.2	18.4	9.8	16.7	13.9	20.3	17.1	12.5	13.1	19.9	18.3	1.6	26.2	7.1	10.8	25.3	17.0	17.3	18.5	11.2	22.3	13.7	16.6	15.7	16.1	18.6	10.0	98.3	64.6	43.8	63.4	35.1	30.0	106.4	73.9	30.8	44.3	52.4	9.8	240.9	167.5	86.8	17.9	51.9	76.6	0.0	73.3	214.7	80.7	31.1	25.5	170.8	104.3	36.5	76.5	49.1	42.8	12.1	173.4	41.1	50.6	74.9	93.0	139.4	66.9	77.2	239.7	228.9	45.0	109.9	78.7	24.1	44.7	20.1	69.5	40.6	88.1	46.7
ANPEP	"CD13, gp150, LAP1, p150, PEPN"	ENSG00000166825	"Alanyl aminopeptidase, membrane"	P15144	15	89784889-89815401	"CD markers, Enzymes, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Differentiation, Host-virus interaction"	"Aminopeptidase, Developmental protein, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 195.3;kidney: 78.7;pancreas: 93.9"	"Cell type enhanced"	"Detected in many"	16	"Cholangiocytes: 372.0;Enterocytes: 993.7;Exocrine glandular cells: 328.5;Proximal tubular cells: 388.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 59.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 59.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 78.5;BJ: 78.2;BJ hTERT+: 111.8;fHDF/TERT166: 67.0;HMC-1: 71.1;HSkMC: 68.7;HUVEC TERT2: 87.5;TIME: 87.4;U-2197: 95.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB002417, HPA004625"	Enhanced		Supported	"Plasma membrane"		NA	NA		1500000000	"Plasma membrane"		"CAB002417: AB_563491, HPA004625: AB_2667199"	"unprognostic (6.31e-2)"	"unprognostic (7.94e-3)"	"unprognostic (6.91e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.50e-1)"	"unprognostic (7.73e-2)"	"unprognostic (5.28e-3)"	"unprognostic (3.96e-1)"	"unprognostic (4.04e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.01e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.99e-2)"	21.3	1.1	0.6	2.9	0.8	9.5	17.0	1.0	1.3	8.2	21.2	0.8	0.5	195.3	1.4	8.4	3.6	1.4	27.7	3.7	0.4	0.3	78.7	37.7	9.7	9.3	0.9	0.9	1.8	93.9	0.0	0.7	14.7	1.3	8.6	4.7	4.0	6.6	1.8	1.6	4.9	155.8	4.3	1.2	7.2	0.8	4.7	0.2	5.6	1.5	4.2	3.8	4.7	3.0	0.0	6.9	59.4	12.8	0.0	0.0	5.5	0.0	5.0	0.0	0.0	61.3	78.5	0.5	78.2	111.8	9.6	8.5	0.5	0.0	0.0	0.9	67.0	0.0	0.0	0.6	0.0	3.8	0.0	0.0	14.7	0.4	11.7	36.1	1.0	71.1	68.7	0.1	30.2	0.0	0.4	87.5	0.0	0.4	0.1	3.7	0.0	0.0	34.7	0.2	0.0	5.3	0.0	0.0	0.8	43.7	0.0	0.1	0.7	0.0	0.1	0.0	0.1	0.0	6.8	87.4	42.2	0.0	95.3	0.0	0.0	0.0	0.0	0.1	0.0	2.2	5.7	12.8	10.4	0.0	7.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	59.4	0.0	12.0	0.1	0.0	5.5	0.6	0.8	1.0	1.3	0.4	0.3	0.9	0.9	1.3	0.2	0.0	4.8	8.2	3.1	8.9	0.0	0.8	372.0	2.7	20.5	19.2	0.0	9.7	36.5	10.6	0.1	1.8	993.7	0.0	328.5	12.0	36.3	18.0	24.2	144.7	39.4	0.0	2.9	101.9	51.7	0.0	2.6	46.4	3.3	39.7	10.5	0.0	120.5	201.5	1.4	388.5	0.0	25.8	5.0	0.4	0.1	5.1	5.4	1.0	18.3	1.3
ESD		ENSG00000139684	"Esterase D"	P10768	13	46771256-46797232	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039700	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		16000000	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA039700: AB_10697553"	"unprognostic (3.05e-1)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (7.66e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (1.73e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.37e-3)"	58.5	30.9	32.0	28.6	29.8	24.2	44.5	23.7	32.0	54.4	37.3	29.0	34.2	31.8	53.2	50.4	54.1	40.6	30.3	45.6	30.7	29.3	58.8	82.2	28.2	31.4	31.7	32.1	61.3	24.9	27.5	47.5	26.4	28.6	55.2	41.7	32.5	31.5	45.2	47.4	29.7	38.4	50.8	37.4	31.1	32.1	32.4	26.7	65.5	78.9	50.9	31.7	62.5	36.9	30.1	48.7	15.1	37.1	29.8	35.7	26.4	22.1	12.9	39.1	26.9	45.9	75.9	10.5	31.9	46.3	44.5	34.7	21.8	27.2	25.2	9.6	38.2	33.3	22.7	43.0	37.7	57.0	28.8	44.7	32.6	13.0	33.5	37.6	63.6	14.0	51.8	35.0	28.7	38.7	53.7	41.7	43.5	31.8	6.8	73.6	21.7	56.4	42.3	10.1	28.7	24.5	44.9	23.0	17.0	63.1	9.0	19.4	22.0	14.2	12.1	25.6	28.1	23.2	36.5	27.8	16.4	19.4	31.5	29.4	4.6	9.9	21.8	35.4	36.5	21.9	7.7	37.1	15.1	15.0	31.5	24.6	30.1	30.0	23.0	40.8	25.3	35.7	27.9	4.3	29.8	28.0	48.7	24.9	26.4	32.0	29.8	23.7	32.0	30.7	29.3	31.7	32.1	28.6	26.7	50.6	42.5	68.7	203.4	119.1	47.0	89.2	124.9	77.6	61.4	146.5	39.3	134.7	305.1	153.5	36.2	95.8	72.1	46.7	90.4	115.2	195.1	96.4	94.6	148.9	197.0	20.6	104.5	112.3	138.2	18.5	247.9	128.5	156.9	100.0	108.9	147.8	82.8	115.8	198.7	400.9	62.5	148.8	210.1	67.4	44.1	113.0	62.2	82.2	173.0	130.7
GCLC	"GCS, GLCL, GLCLC"	ENSG00000001084	"Glutamate-cysteine ligase catalytic subunit"	P48506	6	53497341-53616970	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glutathione biosynthesis"	Ligase	"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 69.2"	"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 102.4;Intestinal endocrine cells: 212.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 8.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 49.2;Hep G2: 42.0;OE19: 68.1;RT4: 45.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009569, HPA036359, HPA036360"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA		3600000	Nucleoplasm	"Nucleoli, Cytosol"	"CAB009569: AB_675582, HPA036359: AB_10672243, HPA036360: AB_10669789"	"unprognostic (8.41e-2)"	"unprognostic (1.27e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.60e-1)"	"unprognostic (7.50e-2)"	"unprognostic (9.94e-3)"	"unprognostic (4.67e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.23e-2)"	"prognostic favorable (3.83e-6)"	"unprognostic (3.78e-2)"	"unprognostic (8.91e-2)"	"prognostic unfavorable (8.24e-4)"	"unprognostic (2.30e-2)"	15.8	11.1	12.9	9.0	16.0	14.4	13.0	5.4	15.1	6.8	16.2	21.6	8.2	18.9	9.2	5.3	20.0	29.1	14.9	7.4	13.1	10.6	15.4	69.2	12.9	10.1	21.6	12.2	6.2	12.4	6.6	5.4	6.2	13.0	13.0	12.2	5.2	11.2	10.1	7.0	8.6	14.8	11.9	13.6	16.8	14.8	5.2	17.5	3.1	14.1	32.4	10.6	34.4	12.3	1.6	4.2	2.2	1.9	8.0	2.3	0.6	7.3	49.2	4.0	9.5	4.8	2.2	5.4	3.7	6.0	2.8	3.3	7.2	17.1	14.0	7.1	3.3	21.5	10.5	12.3	27.1	3.8	11.0	7.6	9.3	9.5	42.0	5.5	12.3	5.8	3.4	11.5	3.1	14.1	3.7	4.2	12.3	5.1	4.4	1.3	7.7	10.5	4.9	7.5	68.1	4.6	3.5	2.5	12.3	9.1	45.4	11.7	5.7	6.2	10.0	6.5	6.1	6.8	5.8	5.9	2.5	8.8	6.4	5.5	5.9	9.1	8.1	6.3	8.8	4.2	2.2	1.1	0.6	1.2	1.9	0.8	1.6	1.0	2.3	4.2	1.0	0.6	1.3	0.5	8.0	1.8	3.0	1.6	0.6	12.9	16.0	5.4	11.9	13.1	10.6	21.6	12.2	13.0	17.5	0.0	3.7	7.8	42.9	30.9	12.8	17.8	25.5	48.2	47.8	0.0	23.6	5.2	10.0	12.8	1.4	13.5	19.9	46.7	11.0	6.5	8.7	44.8	2.3	102.4	19.8	7.9	212.1	9.2	60.1	1.0	6.1	16.4	8.5	6.4	16.3	13.8	17.1	8.5	8.9	19.8	4.0	12.9	10.3	3.3	8.1	21.8	6.5	10.7	13.8	89.1
GCLM	GLCLR	ENSG00000023909	"Glutamate-cysteine ligase modifier subunit"	P48507	1	93885205-93909456	"Cancer-related genes, Predicted intracellular proteins"	"Glutathione biosynthesis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Erythroid cells: 210.2;Glandular cells: 272.8;Urothelial cells: 201.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009568, HPA023696, CAB040554"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		1000000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB009568: AB_2107835, CAB040554: , HPA023696: AB_1849560"	"unprognostic (2.31e-1)"	"unprognostic (7.92e-2)"	"unprognostic (8.85e-3)"	"unprognostic (1.56e-2)"	"unprognostic (2.83e-2)"	"unprognostic (4.64e-2)"	"prognostic unfavorable (9.83e-6)"	"unprognostic (2.37e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.53e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.34e-3)"	10.3	17.5	7.0	6.0	7.7	11.3	23.9	5.7	8.9	4.5	22.8	4.2	11.5	16.6	3.5	6.5	8.8	12.8	12.5	7.7	6.8	8.9	17.8	41.7	8.4	10.4	9.2	5.7	4.6	6.9	6.3	5.1	10.3	8.7	5.3	5.2	6.4	6.7	6.4	19.2	3.4	20.0	3.4	7.7	6.9	6.1	3.2	2.8	5.6	15.0	23.0	8.6	8.9	8.0	3.2	1.9	3.3	0.7	4.6	6.7	1.2	13.1	20.9	2.3	4.5	7.8	4.9	8.9	15.8	9.8	12.0	9.0	3.5	7.8	5.0	31.6	10.2	39.2	13.3	3.4	6.4	9.7	13.5	4.6	34.9	14.2	15.0	14.6	12.8	5.6	6.0	2.4	24.4	3.9	4.8	13.1	5.7	13.8	7.4	8.6	2.5	9.2	3.0	7.9	12.6	10.0	4.3	7.0	7.3	8.5	15.4	5.4	2.2	14.8	11.7	5.5	27.5	2.6	8.0	13.7	12.6	7.4	23.6	23.6	6.7	8.5	5.2	10.4	7.2	4.4	3.3	0.7	1.3	5.3	0.4	3.1	2.6	5.0	6.7	0.6	3.2	3.2	3.2	2.9	4.6	0.5	1.9	1.3	1.2	7.0	7.7	5.7	8.9	6.8	8.9	9.2	5.7	8.7	2.8	38.7	18.4	13.3	119.7	10.2	23.7	13.5	53.5	49.5	19.4	27.9	5.9	60.1	21.6	24.6	3.0	14.5	25.6	210.2	10.7	16.4	25.0	272.8	19.6	71.6	16.8	31.8	50.4	41.7	17.7	1.9	19.8	15.4	8.5	10.8	9.3	19.3	22.5	7.0	11.7	45.8	12.6	0.0	44.3	22.8	40.4	8.2	37.6	34.6	13.2	201.0
GGACT	A2LD1	ENSG00000134864	"Gamma-glutamylamine cyclotransferase"	Q9BVM4	13	100530164-100589528	"Enzymes, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 47.0"	"Cell type enhanced"	"Detected in many"	10	"Proximal tubular cells: 65.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"SCLC-21H: 55.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065320	Enhanced					NA	NA		75000			"HPA065320: AB_2685466"	"unprognostic (1.93e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.30e-3)"	"unprognostic (9.12e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.07e-2)"	"unprognostic (7.41e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.37e-2)"	"unprognostic (2.57e-1)"	3.6	6.6	3.2	3.4	3.4	0.9	3.4	2.6	4.5	2.0	4.9	3.6	1.7	5.7	4.0	3.4	2.8	2.5	5.5	1.7	2.6	2.2	47.0	10.9	2.4	4.6	3.5	2.1	2.5	9.8	1.8	1.9	2.1	4.4	2.4	3.4	4.1	12.0	14.2	2.7	3.1	6.7	3.4	4.3	6.1	4.4	11.0	3.3	3.7	2.5	5.0	6.4	2.5	2.5	5.2	4.2	1.0	7.5	8.0	8.3	4.2	5.6	0.7	4.6	5.0	3.9	6.1	2.0	3.5	0.9	0.6	1.6	0.0	5.1	0.5	2.0	2.5	0.1	0.3	0.7	1.0	0.2	7.9	3.1	2.3	0.5	0.3	5.6	3.3	7.8	7.2	4.0	0.1	0.3	0.0	2.3	2.6	1.2	0.1	0.9	0.3	0.5	0.4	0.2	10.8	1.5	0.3	1.1	0.6	5.7	0.9	55.0	2.1	1.1	2.5	2.5	4.5	2.4	11.2	2.2	0.0	0.0	1.2	0.9	3.0	1.6	0.2	0.3	2.5	2.5	0.0	5.1	1.0	7.9	7.2	7.3	5.2	6.4	8.3	4.2	5.0	4.0	5.9	0.0	8.0	7.5	3.0	6.5	4.2	3.2	3.4	2.6	4.5	2.6	2.2	3.5	2.1	4.4	3.3	0.0	1.0	10.4	3.4	2.4	1.1	0.8	0.0	0.0	2.3	7.0	13.7	9.8	6.6	8.4	4.1	3.1	5.3	0.0	9.0	10.2	2.8	2.2	5.7	13.2	10.5	1.6	7.5	4.3	7.8	6.7	2.6	3.6	0.0	8.2	4.5	4.8	8.0	2.9	3.5	65.3	2.1	6.5	0.9	18.2	10.5	1.8	3.7	5.0	7.1	1.6
GGCT	"C7orf24, CRF21, GCTG, Ggc, MGC3077"	ENSG00000006625	Gamma-glutamylcyclotransferase	O75223	7	30496621-30504844	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 343.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA020735, HPA029914"	Approved					NA	NA		2400000			"HPA020735: AB_1845754, HPA029914: AB_10602321"	"prognostic unfavorable (7.68e-4)"	"unprognostic (2.66e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.54e-3)"	"unprognostic (5.80e-2)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (1.33e-3)"	"unprognostic (2.19e-2)"	"unprognostic (6.42e-3)"	"unprognostic (2.66e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.12e-3)"	"unprognostic (2.00e-3)"	"unprognostic (9.92e-2)"	30.8	18.6	15.5	14.5	15.9	10.2	26.4	10.8	25.6	12.6	20.2	7.3	19.3	16.7	10.4	59.6	33.4	13.5	22.5	12.2	14.6	12.4	22.0	18.7	14.6	13.6	11.6	14.4	15.2	17.2	14.9	11.4	18.5	15.0	14.3	21.9	8.0	23.9	19.2	12.6	29.8	16.8	14.2	9.9	13.2	13.3	8.1	5.8	11.0	28.7	32.1	18.9	17.4	19.1	14.8	21.7	5.6	12.8	15.3	16.4	10.1	40.4	10.6	17.3	23.3	7.3	13.3	20.2	13.8	5.4	13.3	16.2	14.1	14.2	26.2	9.2	5.2	15.1	51.6	18.2	14.5	17.5	5.0	20.1	18.5	21.5	18.5	9.6	31.0	14.3	12.9	11.7	13.9	18.0	4.6	13.4	12.6	26.2	15.1	10.5	22.4	18.7	42.0	25.1	41.6	17.2	18.9	20.1	26.0	12.8	37.0	22.0	22.2	12.4	77.7	14.8	23.5	49.8	29.5	8.0	8.8	16.5	16.6	27.0	11.1	26.2	20.2	6.8	42.2	16.3	5.6	12.8	4.2	9.6	12.5	13.3	14.8	12.7	12.3	21.7	11.7	12.3	11.9	0.7	15.3	7.3	19.1	16.4	10.1	15.5	15.9	10.8	25.6	14.6	12.4	11.6	14.4	15.0	5.8	14.9	29.6	26.1	44.9	68.5	23.0	43.7	20.4	81.7	51.2	41.8	3.9	343.3	104.5	74.5	21.3	42.7	45.1	0.0	69.7	113.6	40.1	51.8	26.5	45.3	113.3	31.8	27.2	28.8	40.5	6.6	23.0	53.5	59.1	21.6	78.5	20.5	50.0	49.1	36.7	159.0	11.6	25.8	43.2	13.5	16.0	65.4	113.4	30.2	117.6	52.0
GGT1	"CD224, D22S672, D22S732, GGT"	ENSG00000100031	"Gamma-glutamyltransferase 1"	P19440	22	24583750-24629005	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Glutathione biosynthesis"	"Acyltransferase, Hydrolase, Protease, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 54.1;seminal vesicle: 41.7"	"Group enriched"	"Detected in many"	6	"Alveolar cells type 1: 74.5;Alveolar cells type 2: 21.4;Cholangiocytes: 40.8;Ductal cells: 54.8;Enterocytes: 80.7;Hepatocytes: 34.1;Pancreatic endocrine cells: 33.5;Paneth cells: 23.0;Proximal tubular cells: 32.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 35.6;Karpas-707: 52.5;OE19: 37.9;RPMI-8226: 51.6;RPTEC TERT1: 48.0"									"HPA045635, HPA047534, HPA065444"	Supported		Uncertain	Vesicles	"Intracellular and membrane"	NA	NA		4600000	Vesicles		"HPA045635: AB_2679400, HPA047534: AB_2680079, HPA065444: AB_2685491"	"unprognostic (8.13e-3)"	"unprognostic (4.76e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.21e-1)"	"prognostic favorable (7.44e-4)"	"unprognostic (4.55e-2)"	"unprognostic (2.55e-2)"	"prognostic favorable (4.83e-4)"	"unprognostic (1.44e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.10e-2)"	1.6	0.5	1.7	1.7	2.2	2.7	8.2	2.3	2.6	7.3	7.9	1.6	23.7	22.3	1.4	19.9	1.2	0.8	12.2	2.0	1.8	1.2	54.1	29.2	14.3	3.2	1.7	1.6	1.3	17.3	0.0	1.6	1.4	2.2	14.7	2.4	1.4	8.7	41.7	0.9	1.1	20.9	1.7	1.9	4.7	6.6	5.0	2.1	2.4	4.8	1.6	5.5	2.1	1.1	3.3	7.5	15.9	14.6	6.6	8.6	6.6	0.2	19.3	0.2	0.0	0.0	0.1	0.5	0.1	0.6	0.2	0.2	2.6	4.2	0.2	4.3	0.0	3.8	2.8	1.4	0.2	0.1	35.6	2.9	0.1	8.6	14.0	1.5	0.3	11.9	0.4	0.2	0.6	0.4	0.3	0.1	5.3	2.0	52.5	0.2	0.4	0.3	14.6	1.4	37.9	0.2	0.2	2.2	51.6	48.0	0.6	0.2	0.3	0.1	9.3	0.2	5.5	9.3	11.1	2.2	3.5	2.3	10.8	0.3	15.8	5.9	0.2	7.4	15.0	0.1	5.2	14.6	0.4	1.4	6.8	5.2	3.3	7.7	3.4	7.5	0.3	1.0	1.9	15.9	6.6	5.5	0.1	8.6	6.6	1.7	2.2	2.3	2.6	1.8	1.2	1.7	1.6	2.2	2.1	74.5	21.4	3.4	0.1	0.7	0.4	0.4	40.8	2.7	7.9	1.8	0.0	0.9	1.7	54.8	1.1	0.1	80.7	0.0	7.2	0.3	1.3	3.0	5.7	34.1	4.7	0.0	1.2	2.5	3.0	4.1	0.0	2.9	1.7	5.4	2.5	2.0	33.5	23.0	0.4	32.7	0.0	0.0	0.2	0.6	0.7	0.4	0.7	3.2	4.2	0.0
GGT2	GGT	ENSG00000133475	"Gamma-glutamyltransferase 2"	P36268	22	21207973-21227637	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"kidney: 5.6;salivary gland: 5.5;thyroid gland: 8.4"	"Cell type enhanced"	"Detected in some"	23	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 7.4;Early spermatids: 3.8;Late spermatids: 14.7"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 1.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.4;HeLa: 4.6;Karpas-707: 2.0;U-2197: 13.9"									"HPA045635, HPA047534, HPA065444"	Supported		Uncertain	Vesicles		NA	NA			Vesicles		"HPA045635: AB_2679400, HPA047534: AB_2680079, HPA065444: AB_2685491"	"unprognostic (4.27e-1)"	"unprognostic (6.91e-2)"		"unprognostic (7.03e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.38e-5)"	"unprognostic (1.05e-3)"		"unprognostic (5.85e-4)"	"unprognostic (7.97e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.46e-3)"	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.1	0.2	0.0			1.4	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.1	2.2	0.0	0.0		0.0	0.1	0.0	0.2	0.0		0.0	0.0		5.5	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.3	1.0			8.4		0.0	0.0	0.0	0.1	0.2	0.4	0.4	0.4	0.5	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	2.4	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.1	0.0	0.0	1.0	0.0	1.5	0.0	0.0	0.1	0.5	0.6	13.9	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.3	0.1	0.5	0.0	0.2	0.0	0.1	0.0	0.4	0.4	0.0	0.0	0.5	0.3											3.0	7.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.7	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.0	0.0
GGT5	"GGT-REL, GGTLA1"	ENSG00000099998	"Gamma-glutamyltransferase 5"	P36269	22	24219654-24245142	"Enzymes, Predicted intracellular proteins"	"Glutathione biosynthesis, Leukotriene biosynthesis"	"Acyltransferase, Hydrolase, Protease, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	19	"Ito cells: 44.2;Sertoli cells: 181.1;Smooth muscle cells: 82.1"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in some"	5	"basophil: 4.0;eosinophil: 7.5;neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 7.5"	"Group enriched"	"Detected in some"	4	"ASC diff: 39.5;ASC TERT1: 30.1;HHSteC: 56.4;HSkMC: 65.0;TIME: 25.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008121, CAB032489"	Uncertain		Approved	"Nucleoli fibrillar center"	"Intracellular and membrane"	NA	NA		18000000	"Nucleoli fibrillar center"		"CAB032489: AB_2111010, HPA008121: AB_1078965"	"unprognostic (8.14e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.66e-2)"	"unprognostic (9.94e-2)"	"unprognostic (8.13e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.37e-2)"	"unprognostic (7.94e-2)"	"prognostic unfavorable (6.36e-5)"	"prognostic unfavorable (4.06e-4)"	"prognostic unfavorable (6.97e-4)"	"unprognostic (1.79e-1)"	"unprognostic (8.33e-2)"	20.2	14.8	2.0	5.2	3.5	0.0	13.2	0.5	4.2	10.7	4.0			5.7	7.9	3.6	2.1	10.2	12.1	14.0	2.4	3.4	13.1	13.7	5.1	12.4	4.7		3.9	5.0	2.2	6.0	3.2		6.5	3.4		5.4	6.8	2.5	5.3	7.2	10.1	2.7	4.8	5.6	1.2			17.2		5.2	6.3	9.3	0.1	0.4	7.5	0.9	0.8	0.1	0.4	0.0	0.3	0.0	0.0	39.5	30.1	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.3	0.1	5.2	56.4	0.6	1.4	65.0	0.0	0.7	0.7	0.0	10.6	0.1	0.1	0.1	10.1	0.1	0.0	4.9	0.6	0.1	0.0	0.0	0.9	0.1	1.1	0.0	0.0	1.4	0.0	1.7	0.0	5.6	0.2	0.3	25.2	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.9	1.1	0.0	4.0	0.9	7.5	0.1	0.4	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	1.9	0.8	0.0	0.1	0.0	0.4											3.0	16.5	0.5	3.1	6.3	0.0	4.8	0.0	2.7	11.4	0.0	0.0	0.2	0.0	0.1	0.5	37.5	0.0	0.0	0.2	0.1	8.7	1.3	1.1	0.0	1.6	0.0	0.0	44.2	1.2	2.6	33.6	2.9	3.3	5.4	0.0	0.2	0.3	0.0	22.3	0.0	0.4	181.1	82.1	0.3	0.4	3.9	0.2	0.0	0.0	0.9
GGT6	FLJ90165	ENSG00000167741	"Gamma-glutamyltransferase 6"	Q6P531	17	4556927-4560818	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Glutathione biosynthesis"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 40.4;salivary gland: 52.7"	"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 136.8;Mucus-secreting cells: 63.3;Paneth cells: 98.2;Undifferentiated cells: 77.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 3.5"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.5"	"Group enriched"	"Detected in some"	8	"RT4: 30.5;SK-BR-3: 10.4;T-47d: 32.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA023362, HPA027213"	Approved					NA	NA		33000			"HPA023362: AB_1848955, HPA027213: AB_10601326"	"unprognostic (2.23e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.14e-3)"	"unprognostic (4.51e-2)"	"unprognostic (9.71e-2)"	"unprognostic (7.67e-3)"	"unprognostic (1.29e-1)"	"prognostic favorable (4.35e-4)"	"unprognostic (2.10e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.07e-2)"	"unprognostic (5.06e-2)"	"prognostic favorable (9.42e-7)"	"unprognostic (1.56e-1)"	"unprognostic (5.71e-2)"	"unprognostic (9.17e-2)"	"unprognostic (8.07e-3)"	0.3	0.4	0.3	12.7	0.3	0.0	3.2	0.3	0.4	4.1	24.9	0.4	1.0	17.0	0.9	15.9	25.2	3.0	7.7	0.3	0.3	0.1	18.8	0.6	4.2	0.3	0.3	0.3	1.5	28.6	0.0	1.0	0.4	0.4	5.7	12.7	0.4	52.7	3.7	0.3	25.2	40.4	2.8	0.3	0.3	8.7	0.8	0.3	1.0	0.7	19.6	18.8	16.5	8.2	0.6	0.7	3.5	0.5	0.6	0.5	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	3.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	30.5	0.1	0.1	0.0	10.4	0.0	0.0	32.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.5	0.5	0.2	0.4	0.3	0.2	0.3	0.5	0.3	0.1	0.6	0.5	0.4	1.9	0.6	0.5	0.7	0.4	0.0	0.3	0.3	0.3	0.4	0.3	0.1	0.3	0.3	0.4	0.3	32.8	5.8	2.2	16.1	3.7	0.0	0.2	17.8	33.5	29.6	22.7	2.0	0.0	18.3	16.4	0.0	0.0	136.8	0.0	33.4	0.0	0.3	3.4	0.0	0.0	0.1	0.0	5.8	0.0	0.0	0.0	0.6	1.3	0.0	3.6	63.3	0.2	14.4	98.2	0.0	32.1	0.2	0.0	1.0	0.0	0.1	18.2	0.0	0.5	77.9	19.7
GGT7	"D20S101, dJ18C9.2, GGTL3, GGTL5"	ENSG00000131067	"Gamma-glutamyltransferase 7"	Q9UJ14	20	34844720-34872860	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Glutathione biosynthesis"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 38.6;Horizontal cells: 38.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013204, HPA013339"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		1500000	Vesicles	Nucleoplasm	"HPA013204: AB_1850347, HPA013339: AB_2668816"	"unprognostic (1.32e-3)"	"unprognostic (2.33e-1)"	"unprognostic (9.31e-2)"	"prognostic unfavorable (1.26e-5)"	"unprognostic (1.27e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.46e-3)"	"unprognostic (2.49e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.34e-3)"	"unprognostic (3.61e-2)"	"unprognostic (5.00e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.00e-1)"	6.8	6.7	21.6	6.7	23.7	2.9	8.5	42.6	29.1	9.5	11.5	9.7	14.3	9.8	12.3	19.5	6.4	10.5	11.4	13.8	19.7	17.0	9.9	7.2	9.0	10.3	11.2	32.1	13.4	19.5	20.8	18.3	8.5	19.2	11.4	9.6	6.9	18.8	15.3	31.6	11.1	9.0	9.6	11.0	8.3	12.9	5.0	15.6	4.9	16.3	4.3	8.2	9.3	8.5	6.1	2.6	1.5	3.0	3.2	12.8	1.8	2.2	3.3	17.0	17.4	13.4	12.0	15.1	9.4	9.6	7.8	11.6	17.4	11.1	0.0	11.2	7.3	7.9	1.5	7.3	4.1	5.1	0.7	13.1	6.7	5.9	9.1	12.0	0.3	11.1	17.4	4.7	8.7	4.0	23.3	0.6	8.9	5.0	1.2	5.3	3.8	1.7	3.4	3.9	3.8	1.7	0.0	11.6	10.7	11.3	3.3	9.9	11.6	4.8	7.7	12.1	6.7	5.9	6.1	0.2	26.8	10.7	2.5	5.3	13.1	1.7	0.8	31.5	0.6	9.8	1.5	3.0	1.4	7.4	2.0	2.1	5.6	6.3	2.8	2.6	6.1	12.8	8.9	0.3	3.2	0.7	1.4	4.8	1.8	21.6	23.7	42.6	29.1	19.7	17.0	11.2	32.1	19.2	15.6	3.0	2.4	0.9	17.1	6.5	38.6	1.6	22.9	1.4	3.4	17.4	11.8	18.6	0.0	13.9	2.1	2.1	10.5	0.0	4.9	9.8	11.9	9.2	2.3	10.2	4.0	38.1	10.4	0.6	1.9	0.5	11.5	2.4	10.1	3.6	16.0	9.4	6.7	14.0	7.4	5.1	16.9	6.5	8.6	11.1	10.6	3.8	14.1	4.1	17.8	12.0
GGTLC1	"dJ831C21.1, dJ831C21.2, GGTLA3, GGTLA4"	ENSG00000149435	"Gamma-glutamyltransferase light chain 1"	Q9BX51	20	23985050-23988779	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	13	"lung: 24.2;testis: 11.1"	"Group enriched"	"Detected in some"	6	"Alveolar cells type 1: 128.1;Early spermatids: 37.6;Late spermatids: 92.1"	"Cancer enriched"	"Detected in some"	8	"lung cancer: 7.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 1.3;SK-BR-3: 1.7;T-47d: 1.2;U-2197: 4.5"									"HPA045635, HPA047534"	Uncertain					NA	NA					"HPA045635: AB_2679400, HPA047534: AB_2680079"				"unprognostic (3.14e-1)"			"unprognostic (1.62e-1)"	"unprognostic (1.94e-2)"			"unprognostic (5.32e-1)"	"unprognostic (4.19e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.41e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.2	0.0	0.0		0.0	0.2	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1			1.4		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.8	0.1	0.0	0.0	1.7	0.0	0.0	1.2	0.0	0.0	0.0	0.1	4.5	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2											128.1	14.9	0.0	0.0	0.0	0.0	0.0	5.1	0.0	4.5	0.0	0.0	0.0	0.0	0.0	37.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	92.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	7.9	0.4	0.0	0.0	0.0	0.0	0.0
GGTLC2	GGTL4	ENSG00000100121	"Gamma-glutamyltransferase light chain 2"	Q14390	22	22644475-22647903	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	7	"testis: 11.1"	"Cell type enhanced"	"Detected in some"	18	"Alveolar cells type 1: 20.8;Early spermatids: 22.5;Late spermatids: 5.2;Spermatocytes: 10.9"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.6;RPMI-8226: 4.6;THP-1: 2.8;U-2 OS: 2.4"									"HPA045635, HPA047534"	Uncertain					NA	NA					"HPA045635: AB_2679400, HPA047534: AB_2680079"				"unprognostic (2.58e-2)"			"unprognostic (2.35e-2)"	"unprognostic (7.17e-2)"		"unprognostic (2.96e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.48e-2)"		"unprognostic (1.55e-1)"		0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0			0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.2	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.2	0.0		0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	11.1			0.2		0.0	0.0	0.0	0.3	0.9	1.4	1.3	0.8	0.7	0.6	0.0	0.5	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	4.6	1.0	0.0	0.0	0.1	0.0	0.5	0.0	0.2	0.3	2.8	0.0	0.0	2.4	0.0	0.0	0.7	0.5	0.1	0.0	0.2	0.0	0.5	1.3	0.0	0.0	0.5	0.2	0.3	0.7	0.4	0.9	0.0	0.0	0.3	1.4	0.8	0.7	0.0	0.7	0.6											20.8	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	5.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	10.9	0.1	0.0	0.0	0.0	0.0	0.0
GGTLC3		ENSG00000274252	"Gamma-glutamyltransferase light chain family member 3"	B5MD39	22	18516344-18518161	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"lung: 4.2;salivary gland: 3.0"	"Group enriched"	"Detected in some"	21	"Alveolar cells type 1: 3.0;Early spermatids: 4.1;Late spermatids: 10.4;Spermatocytes: 6.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.9;SuSa: 5.3;U-2197: 3.6"									"HPA045635, HPA047534"	Uncertain					NA	NA					"HPA045635: AB_2679400, HPA047534: AB_2680079"													"unprognostic (1.37e-1)"			"unprognostic (2.06e-4)"		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			1.2	0.0	0.0	0.0	0.0	0.0	0.0			0.9	0.0	4.2	0.0			0.0	0.9	0.0		0.0		0.0	0.0		3.0	0.0	0.0	0.0	1.2	0.0		0.0	0.7	1.5			0.7		0.0	0.0		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.7	0.1	0.0	0.5	1.2	0.0	0.0	1.2	0.3	0.0	0.7	0.6	1.1	0.3	0.0	0.0	5.3	0.0	0.0	0.0	0.3	1.4	3.6	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0											3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0
GPX2	GSHPX-GI	ENSG00000176153	"Glutathione peroxidase 2"	P18283	14	64939152-64942905	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Oxidoreductase, Peroxidase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 126.9;liver: 195.2"	"Cell type enhanced"	"Detected in many"	9	"Cholangiocytes: 484.1;Hepatocytes: 821.3;Mucus-secreting cells: 410.2;Undifferentiated cells: 621.9;Urothelial cells: 833.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cell: 2.4"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	4	"OE19: 309.4"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.3"	"Not detected"	"Not detected"			HPA003545	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA003545: AB_10962695"	"unprognostic (3.54e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.90e-3)"	"unprognostic (4.75e-3)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (2.96e-2)"	"unprognostic (2.93e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.77e-2)"	"unprognostic (4.39e-2)"	"unprognostic (3.39e-2)"	"unprognostic (6.66e-4)"	"unprognostic (1.73e-2)"	0.1	0.0	0.1	23.8	0.2	0.0	0.8	0.2	0.1	5.5	50.4	0.5	2.0	14.4	0.3	1.0	53.0	0.6	126.9	0.2	0.1	0.2	29.4	195.2	2.0	0.1	0.1	0.1	0.9	7.0	0.0	0.2	0.1	0.2	16.8	71.6	0.1	59.7	4.1	0.3	3.9	35.4	5.6	0.2	0.1	57.8	0.4	0.1	0.5	0.2	44.0	7.4	56.3	15.0	0.2	0.0	0.5	0.8	2.4	0.1	0.0	0.0	71.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.6	0.0	0.4	0.0	0.1	19.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	66.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	309.4	0.0	0.0	0.0	0.0	0.0	47.5	21.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.5	2.4	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.0	0.0	11.8	173.3	8.9	0.1	0.4	484.1	2.7	2.3	22.7	0.0	0.1	10.0	152.1	13.5	0.5	203.5	0.0	233.6	0.1	0.4	34.2	13.8	821.3	0.0	0.0	110.6	14.1	19.9	38.7	0.9	0.3	0.0	5.4	410.2	0.0	220.5	261.9	0.0	18.9	0.6	0.0	1.0	0.5	0.0	8.4	0.0	6.9	621.9	833.9
GPX3		ENSG00000211445	"Glutathione peroxidase 3"	P22352	5	151020438-151028993	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 844.2;thyroid gland: 424.1"	"Group enriched"	"Detected in many"	4	"Muller glia cells: 3198.5;Proximal tubular cells: 9534.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 856.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 16.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 16.7"	"Cell line enriched"	"Detected in some"	12	"ASC diff: 427.5"	"Region enhanced"	"Detected in many"		"hypothalamus: 279.6"	"Group enriched"	"Detected in many"	4	"basal ganglia: 67.2;hypothalamus: 176.5;midbrain: 58.6;pons and medulla: 52.3"	CAB069456	Approved				"Secreted to blood"	NA	NA	5090000000	10000000000			"CAB069456: AB_1616682"	"unprognostic (4.03e-1)"	"unprognostic (7.35e-2)"	"unprognostic (5.05e-3)"	"unprognostic (9.01e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.70e-3)"	"unprognostic (8.17e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.95e-1)"	"prognostic unfavorable (1.65e-4)"	"unprognostic (2.14e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.26e-1)"	177.5	21.9	1.2	6.6	5.5	1.6	310.9	3.1	6.3	26.2	33.9	5.1	6.5	7.5	11.8	16.8	44.4	27.0	17.3	108.1	2.7	5.0	844.2	64.1	88.2	43.8	3.9	1.8	28.8	13.0	5.5	32.3	44.8	17.6	41.3	8.3	160.8	14.8	12.4	56.7	18.7	18.5	48.5	3.5	29.6	19.5	23.6	1.2	0.5	424.1	19.0	9.8	58.8	164.2	0.0	3.5	16.7	3.6	0.0	0.2	1.2	0.1	0.5	0.4	0.1	427.5	0.3	0.4	0.1	0.0	0.4	0.1	9.1	0.2	0.0	11.7	0.2	0.1	0.1	2.1	23.0	0.3	0.3	0.1	0.0	0.2	9.9	16.4	0.0	0.2	36.1	2.2	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.5	1.6	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	4.0	0.2	0.6	0.6	0.0	1.7	0.1	1.9	2.3	0.1	0.1	0.1	1.0	0.2	0.0	0.1	0.7	0.1	0.3	0.1	0.0	0.0	3.6	0.1	0.0	1.4	0.2	0.0	0.0	0.0	3.5	0.0	0.0	0.0	16.7	0.0	0.1	0.0	0.0	1.2	1.2	5.5	3.1	3.6	2.7	5.0	3.9	1.8	17.6	1.2	8.9	50.9	26.2	69.3	16.5	21.7	621.6	15.3	28.1	26.1	615.9	41.2	663.5	1502.1	3.9	2.4	100.8	0.7	0.0	42.8	818.8	102.8	81.4	10.5	137.7	137.1	15.9	43.8	697.9	65.5	7.5	413.6	35.5	21.9	1.0	5.6	3198.5	11.1	7.0	38.5	9534.8	68.9	672.6	191.9	3.8	10.7	18.9	1478.3	13.8	0.6	29.7
GPX4	"MCSP, PHGPx"	ENSG00000167468	"Glutathione peroxidase 4"	P36969	19	1103926-1106791	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Developmental protein, Oxidoreductase, Peroxidase"	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Late spermatids: 13901.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008630, HPA047224, HPA058546"	Enhanced		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA		220000	"Nucleoplasm, Mitochondria"		"CAB008630: AB_1616685, HPA047224: AB_2679990, HPA058546: AB_2683749"	"unprognostic (8.42e-3)"	"prognostic favorable (7.18e-4)"	"unprognostic (8.14e-3)"	"prognostic favorable (1.84e-5)"	"unprognostic (1.00e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.53e-3)"	"unprognostic (8.49e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (7.72e-4)"	"unprognostic (1.29e-1)"	"prognostic favorable (8.61e-4)"	"unprognostic (1.61e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.67e-3)"	"unprognostic (2.96e-2)"	163.0	76.4	63.3	27.1	73.7	33.3	102.3	33.5	83.7	53.3	49.1	42.4	33.8	56.9	27.2	74.7	35.6	38.4	46.9	64.4	54.2	60.2	75.3	119.0	44.7	41.7	74.6	47.3	47.1	35.1	33.1	54.7	46.4	49.3	44.7	25.5	82.3	61.6	46.9	98.2	36.3	58.5	43.6	46.5	32.4	27.7	170.4	36.5	29.9	52.8	49.8	39.2	51.2	47.0	56.7	64.0	85.2	85.2	28.4	58.5	110.5	28.7	32.7	47.3	100.0	143.5	85.1	52.7	22.8	82.3	43.5	44.4	66.7	39.0	10.4	24.9	46.0	36.8	32.4	27.6	33.0	21.3	58.3	49.9	19.6	29.4	94.1	83.5	23.0	31.5	84.4	50.3	22.0	37.1	78.5	60.8	36.5	27.4	26.3	35.9	73.8	38.9	39.5	44.8	64.1	52.8	53.9	6.4	30.1	47.2	71.5	40.8	25.8	44.7	42.4	46.4	30.3	41.4	56.3	51.4	46.3	30.8	79.3	28.5	92.2	62.5	24.3	43.6	46.2	26.5	75.6	85.2	85.2	37.0	62.0	43.0	56.7	54.3	38.6	64.0	47.8	58.5	41.7	42.4	28.4	68.3	44.1	46.8	110.5	63.3	73.7	33.5	83.7	54.2	60.2	74.6	47.3	49.3	36.5	166.7	171.0	287.8	409.7	453.0	334.7	225.6	313.4	467.1	233.2	448.4	92.3	508.2	1349.6	448.1	3338.1	251.8	690.8	163.5	318.5	1086.5	512.4	561.5	339.3	667.2	1047.6	197.0	381.4	302.0	479.7	13901.3	356.4	828.7	642.7	2643.8	270.1	239.3	473.5	361.2	294.2	2040.3	183.4	239.3	381.6	862.4	171.8	408.3	818.0	223.7	258.1	558.8
GPX5		ENSG00000224586	"Glutathione peroxidase 5"	O75715	6	28525925-28534952	"Enzymes, Predicted secreted proteins"		"Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"epididymis: 27.7"	"Group enriched"	"Detected in some"	32	"Early spermatids: 10.4;Late spermatids: 26.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"BEWO: 1.0;NB-4: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted in male reproductive system"	NA	NA																	"unprognostic (3.34e-2)"			"unprognostic (3.74e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0
GPX6	GPXP3	ENSG00000198704	"Glutathione peroxidase 6"	P59796	6	28503296-28528215	"Enzymes, Predicted secreted proteins"		"Oxidoreductase, Peroxidase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"epididymis: 9.3"	"Cell type enhanced"	"Detected in some"	22	"Early spermatids: 2.5;Late spermatids: 2.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.0;HEL: 1.6"	"Region enriched"	"Detected in single"	16	"basal ganglia: 21.3"	"Not detected"	"Not detected"								"Secreted in male reproductive system"	NA	NA																				"unprognostic (2.99e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.1	0.0	0.0	0.4	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9			0.0		0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0
GPX7	"FLJ14777, GPX6, NPGPx"	ENSG00000116157	"Glutathione peroxidase 7"	Q96SL4	1	52602372-52609051	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"		"Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 22.8;HEL: 21.0;REH: 25.0;RPMI-8226: 42.2;THP-1: 33.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA						"unprognostic (5.87e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.78e-1)"	"unprognostic (7.43e-3)"	"unprognostic (3.18e-1)"	"unprognostic (5.64e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.73e-1)"	"unprognostic (4.42e-2)"	"unprognostic (8.18e-2)"	"unprognostic (4.17e-1)"	"unprognostic (2.48e-3)"	"prognostic unfavorable (2.26e-5)"	"unprognostic (1.14e-2)"	"unprognostic (9.24e-2)"	"unprognostic (3.08e-2)"	"unprognostic (5.44e-2)"	8.6	9.4	6.9	10.1	7.5	13.8	10.4	5.8	5.8	13.7	9.6	6.6	6.2	2.8	14.8	6.8	5.5	11.1	12.0	11.0	5.2	4.9	9.9	5.5	7.3	12.8	5.5	4.2	14.1	18.3	9.9	15.4	32.9	6.8	11.1	5.1	10.0	7.7	9.2	9.3	5.7	6.5	9.7	5.2	9.3	6.0	7.8	5.2	22.6	20.5	7.9	14.1	14.0	8.2	13.6	29.8	2.0	0.6	12.0	19.8	9.3	0.0	0.0	6.2	11.5	2.3	6.7	0.0	4.2	0.2	5.1	5.3	4.0	0.0	0.0	3.4	22.8	0.0	0.0	9.8	0.0	2.8	0.0	0.0	21.0	1.2	3.7	8.4	0.0	0.0	15.5	0.0	0.8	0.0	0.0	7.7	0.1	0.0	0.0	9.5	0.0	1.0	10.9	10.7	0.0	0.0	25.0	0.0	42.2	0.4	0.0	4.7	9.3	11.1	0.0	7.2	1.0	0.0	33.4	0.4	0.0	1.3	1.3	0.0	0.0	0.0	15.6	0.0	0.0	3.8	0.0	0.6	2.0	9.9	0.1	13.6	13.6	15.1	11.6	2.2	13.3	19.8	12.8	0.3	12.0	0.0	29.8	10.8	9.3	6.9	7.5	5.8	5.8	5.2	4.9	5.5	4.2	6.8	5.2	3.0	5.6	19.2	9.6	1.9	0.9	3.7	10.2	10.7	9.1	3.5	0.0	18.6	5.0	11.2	5.0	4.4	0.0	0.0	13.7	18.3	24.5	4.9	1.1	3.4	10.3	4.8	1.2	20.9	1.8	4.9	14.1	5.2	6.8	4.6	0.7	7.7	6.1	0.0	12.7	2.6	0.5	12.9	4.1	10.0	8.1	2.9	13.0	7.9	0.0	3.3
GPX8	"EPLA847, UNQ847"	ENSG00000164294	"Glutathione peroxidase 8 (putative)"	Q8TED1	5	55160118-55167071	"Enzymes, Predicted intracellular proteins"		"Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	15	"Extravillous trophoblasts: 185.8;Fibroblasts: 64.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 52.6;fHDF/TERT166: 49.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036720	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Actin filaments"	"HPA036720: AB_2675269"	"unprognostic (4.85e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.31e-2)"	"unprognostic (9.74e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.07e-2)"	"unprognostic (4.34e-2)"	"unprognostic (4.31e-2)"	"unprognostic (8.68e-2)"	"prognostic unfavorable (5.13e-9)"	"prognostic unfavorable (7.96e-4)"	"unprognostic (8.11e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.63e-2)"	12.6	7.1	0.8	5.8	1.0	0.0	12.2	0.5	0.7	31.4	6.8	1.7	17.3	1.3	23.6	34.5	13.3	13.2	11.2	12.1	1.0	0.9	13.7	2.6	7.3	5.6	1.1	0.9	31.5	5.0	4.5	3.2	40.9	4.0	24.2	4.7	17.8	7.3	16.7	5.0	5.1	4.4	14.1	3.3	7.5	4.9	10.2	0.5	0.7	28.4	11.0	5.4	15.8	19.7	1.0	0.7	2.4	0.5	0.6	0.9	0.2	7.1	5.9	13.0	12.6	34.3	39.0	7.1	36.2	52.6	20.4	40.7	0.6	16.2	0.0	38.6	49.2	17.4	6.1	7.7	10.5	28.0	0.0	3.2	0.3	10.6	1.3	10.8	0.0	0.0	27.6	10.5	12.4	6.5	19.2	23.6	0.0	0.2	0.0	23.1	2.2	0.0	0.0	5.9	0.2	8.4	0.0	7.4	0.0	12.5	0.2	0.0	0.3	12.1	0.9	12.8	15.5	11.6	0.7	21.2	10.9	12.0	16.1	19.4	0.0	0.0	0.0	17.3	0.0	23.6	1.4	0.5	0.3	0.5	0.3	0.5	0.6	0.5	0.5	0.2	1.0	0.9	0.9	2.4	0.6	0.3	0.7	0.2	0.2	0.8	1.0	0.5	0.7	1.0	0.9	1.1	0.9	4.0	0.5	0.0	0.6	0.0	4.8	6.4	0.0	2.6	0.0	14.7	13.6	24.4	0.0	48.1	5.0	12.0	0.4	13.5	0.0	0.0	34.7	185.8	64.1	2.1	4.6	0.0	9.1	0.0	0.0	19.0	0.0	0.2	47.5	1.3	23.6	1.8	3.6	6.6	18.2	0.0	37.4	0.2	0.2	12.9	11.2	0.1	0.1	5.4	11.1	0.7	0.8	1.8
GSR		ENSG00000104687	"Glutathione-disulfide reductase"	P00390	8	30678061-30727999	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes, Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 61.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001538, CAB008632, HPA064806"	Approved		Supported	Cytosol		NA	NA		110000000	Cytosol		"CAB008632: AB_1616690, HPA001538: AB_1078986, HPA064806: "	"unprognostic (1.23e-1)"	"prognostic favorable (3.37e-4)"	"prognostic favorable (4.08e-5)"	"unprognostic (2.89e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.50e-1)"	"prognostic unfavorable (3.26e-5)"	"unprognostic (3.61e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.83e-2)"	"unprognostic (6.92e-3)"	"prognostic favorable (1.80e-4)"	"unprognostic (2.31e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.29e-1)"	8.9	14.4	6.8	10.7	9.1	7.9	6.2	9.1	11.8	18.6	18.7	7.1	18.4	20.4	13.2	12.0	19.4	8.8	17.3	11.9	5.0	5.7	27.9	17.8	10.8	9.7	4.9	6.0	11.8	17.6	22.9	7.2	8.9	6.8	16.4	17.2	10.9	12.0	17.4	14.7	6.5	31.8	9.3	4.5	13.6	17.7	7.9	4.2	17.0	9.2	11.8	12.0	23.9	14.5	2.5	4.7	19.0	5.7	2.6	7.3	2.1	11.6	49.4	8.0	6.2	8.6	9.7	7.7	5.2	11.5	7.4	10.0	14.5	6.2	22.8	25.8	6.7	22.0	13.1	12.1	11.3	8.2	5.9	11.2	23.0	17.1	48.5	23.2	7.0	37.0	16.1	7.1	11.1	4.5	8.1	10.5	14.5	19.0	10.1	16.7	10.6	24.7	8.2	14.2	48.3	8.8	9.4	9.2	11.0	14.8	29.6	6.1	7.8	7.2	16.8	12.5	11.2	7.2	8.0	14.3	3.1	8.6	7.3	7.7	5.6	6.2	14.7	9.9	9.9	10.1	19.0	4.6	11.5	4.2	4.2	7.3	2.5	3.8	4.6	4.7	2.0	2.4	3.1	6.5	2.6	5.7	2.9	3.2	2.1	6.8	9.1	9.1	11.8	5.0	5.7	4.9	6.0	6.8	4.2	3.0	21.0	15.2	10.5	3.8	6.1	21.4	30.6	9.4	14.8	12.2	15.7	11.8	8.3	9.6	6.9	8.0	61.3	0.0	17.1	5.3	5.4	23.6	5.8	37.6	15.4	3.2	32.7	15.4	38.4	14.1	6.6	12.8	8.5	5.4	52.8	11.8	14.3	34.0	10.3	14.4	7.5	6.5	6.2	1.2	4.4	4.6	5.4	11.3	38.8	23.0
GSS		ENSG00000100983	"Glutathione synthetase"	P48637	20	34928433-34956027	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Glutathione biosynthesis"	Ligase	"Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054508, HPA059315"	Enhanced		Supported	Nucleoplasm		NA	NA		23000000	Nucleoplasm		"HPA054508: AB_2682509, HPA059315: AB_2683976"	"unprognostic (5.80e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.21e-2)"	"unprognostic (3.63e-2)"	"unprognostic (5.68e-2)"	"prognostic unfavorable (7.21e-5)"	"unprognostic (2.90e-2)"	"unprognostic (8.52e-2)"	"unprognostic (3.64e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (7.31e-6)"	"unprognostic (3.35e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.52e-1)"	12.9	29.8	14.7	13.2	21.0	16.0	16.2	9.2	27.6	12.7	26.9	17.2	28.9	20.0	11.5	47.5	25.6	18.5	18.3	14.6	15.0	15.9	30.5	30.9	12.1	11.7	15.1	15.1	11.6	10.3	17.5	15.6	27.2	15.3	18.6	27.6	15.4	19.1	19.4	10.7	19.1	21.4	12.9	13.3	13.3	15.7	16.8	9.2	17.0	18.0	12.0	21.0	14.4	13.9	7.3	24.3	7.9	21.3	15.2	18.3	14.9	18.2	22.2	10.9	15.3	12.7	13.2	15.5	15.6	14.4	24.6	20.4	40.7	22.3	12.9	20.8	16.0	23.8	17.4	15.9	39.7	20.8	6.0	9.0	51.0	14.1	40.4	17.9	12.8	18.0	13.9	42.5	23.1	39.1	11.0	17.4	17.6	24.6	10.6	29.8	20.1	20.4	18.2	6.4	24.1	28.7	18.8	21.9	30.7	35.2	18.7	21.4	12.5	27.5	25.8	20.5	6.2	31.7	11.7	13.7	28.3	16.1	18.6	13.4	10.8	10.0	14.2	24.1	14.1	16.8	7.9	20.3	4.6	18.0	21.3	16.1	7.3	14.5	18.3	24.3	5.2	16.9	14.3	5.3	15.2	19.0	13.5	17.5	14.9	14.7	21.0	9.2	27.6	15.0	15.9	15.1	15.1	15.3	9.2	17.9	8.0	10.4	28.7	23.4	20.6	14.0	30.6	8.1	12.5	24.4	9.8	69.5	21.6	40.0	44.5	14.6	44.5	0.0	41.7	42.0	15.3	18.9	17.3	23.3	52.3	33.4	22.5	5.5	16.2	108.3	9.5	20.4	15.1	40.5	44.4	26.6	32.4	28.8	17.3	95.3	15.4	25.8	12.2	16.4	14.7	21.1	41.0	20.3	70.9	22.9
LAP3	"LAP, LAPEP, PEPS"	ENSG00000002549	"Leucine aminopeptidase 3"	P28838	4	17577192-17607972	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hofbauer cells: 227.4;monocytes: 251.5;Proximal tubular cells: 217.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029606, HPA029607"	Enhanced		Supported	Nucleoplasm,Midbody,Cytosol		Yes	No		4100000	Cytosol	"Nucleoplasm, Midbody"	"HPA029606: AB_10599288, HPA029607: AB_10611381"	"unprognostic (2.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.61e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.29e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.06e-1)"	"unprognostic (8.79e-2)"	42.5	29.7	23.2	43.9	38.5	18.1	30.7	8.5	23.5	13.3	21.0	23.5	12.3	27.5	17.2	20.8	19.3	18.7	24.3	25.4	24.4	17.0	71.7	70.3	39.4	54.2	33.7	16.1	13.5	14.7	23.5	13.2	25.0	34.9	15.3	22.7	15.0	23.0	12.1	33.3	20.9	30.6	26.9	35.0	54.9	20.8	19.3	30.7	19.9	29.4	21.7	32.1	24.4	23.7	7.5	45.7	9.5	46.1	11.8	12.9	25.3	10.9	9.6	9.2	8.7	18.3	22.3	0.1	17.3	19.5	62.9	76.5	17.5	20.9	43.2	11.5	13.3	37.5	6.8	34.5	12.2	24.0	16.4	9.9	23.9	10.6	22.8	21.3	21.5	15.4	22.7	7.8	20.6	10.9	7.2	21.8	11.4	23.1	30.9	14.8	11.8	19.1	29.5	19.2	20.6	18.4	29.7	8.8	21.8	16.4	12.9	13.6	11.2	15.8	9.8	33.8	13.3	8.3	8.3	14.1	16.0	10.8	16.8	30.0	28.4	43.4	37.3	21.6	35.9	15.4	8.4	43.4	9.5	8.0	46.1	7.4	7.5	7.5	8.5	45.7	5.2	6.5	6.8	6.2	11.8	31.9	25.9	12.9	25.3	23.2	38.5	8.5	23.5	24.4	17.0	33.7	16.1	34.9	30.7	26.8	44.7	44.2	21.0	19.6	8.0	43.2	10.2	46.8	26.1	26.2	2.0	31.2	99.5	46.8	71.4	104.1	38.5	0.0	96.6	44.5	25.9	23.1	63.4	92.3	227.4	6.4	15.6	68.2	96.6	22.8	21.3	135.7	40.5	251.5	30.0	93.7	42.5	30.2	32.9	217.2	12.6	32.3	24.7	46.4	13.2	19.9	46.6	30.5	39.9	21.7
NPEPPS	"MP100, PSA"	ENSG00000141279	"Aminopeptidase puromycin sensitive"	P55786	17	47522942-47623276	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 253.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 81.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021453, HPA045649"	Uncertain		Supported	Cytosol		No	No		2100000	Cytosol		"HPA021453: AB_2670709, HPA045649: AB_2679406"	"unprognostic (1.63e-1)"	"unprognostic (3.15e-2)"	"prognostic favorable (3.39e-5)"	"unprognostic (2.66e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (3.67e-5)"	"unprognostic (3.84e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.07e-1)"	16.0	26.0	27.2	15.9	27.7	11.1	56.1	36.5	33.8	17.1	17.7	9.8	14.6	14.6	16.9	17.1	47.7	17.2	16.3	22.2	24.0	15.6	18.8	11.1	30.3	24.1	16.0	29.7	20.8	16.8	21.2	15.3	17.6	27.2	18.6	20.0	13.3	21.8	16.5	52.3	29.6	17.3	20.4	22.8	15.7	16.2	15.3	16.1	7.0	14.5	14.8	18.1	19.0	30.5	6.9	9.0	23.2	8.6	9.3	9.2	5.4	32.7	21.6	21.8	15.3	25.1	25.4	45.9	14.5	18.8	21.9	21.4	13.9	37.7	19.6	22.4	21.1	19.9	20.0	23.9	13.3	34.2	8.7	20.6	23.5	22.3	16.1	14.5	13.3	15.3	19.4	13.2	15.9	8.4	32.0	22.5	6.8	19.8	11.4	31.1	8.8	17.6	11.9	13.3	18.5	19.6	14.3	30.6	17.3	27.4	24.0	17.4	15.0	18.6	10.9	12.9	38.4	81.1	9.3	28.8	14.7	10.6	21.8	10.1	23.4	22.5	11.9	20.7	7.0	9.6	10.2	8.6	10.7	9.1	6.6	9.2	6.8	7.3	8.5	8.7	6.9	6.5	7.6	23.2	9.3	6.8	9.0	8.4	5.4	27.2	27.7	36.5	33.8	24.0	15.6	16.0	29.7	27.2	16.1	77.4	58.6	28.2	59.7	69.1	136.0	50.0	50.9	29.4	39.8	40.1	253.3	68.9	23.2	54.3	25.4	43.7	53.1	0.0	47.2	63.0	58.6	89.0	39.4	26.9	35.7	106.5	42.6	39.3	44.0	43.4	48.9	38.9	55.6	26.2	41.6	39.6	80.1	54.0	47.0	38.3	167.1	77.6	44.8	47.1	27.9	89.6	87.5	32.0	44.8	147.8
OPLAH	"5-Opase, OPLA"	ENSG00000178814	"5-oxoprolinase, ATP-hydrolysing"	O14841	8	144051266-144063965	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 49.3"	"Group enriched"	"Detected in many"	4	"Early spermatids: 97.1;Late spermatids: 174.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 3.0;intermediate monocyte: 1.0;neutrophil: 3.8"	"Group enriched"	"Detected in many"	9	"granulocytes: 3.8;monocytes: 3.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 22.7;BEWO: 14.2;Hep G2: 12.2;PC-3: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026562, HPA028260, HPA052429"	Uncertain		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA026562: AB_1854804, HPA028260: AB_10601383, HPA052429: AB_2681830"	"unprognostic (7.89e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.69e-1)"	"unprognostic (9.09e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.87e-3)"	"unprognostic (2.04e-2)"	"unprognostic (9.37e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.82e-2)"	"unprognostic (3.62e-1)"	"prognostic favorable (1.53e-6)"	"unprognostic (4.03e-3)"	"unprognostic (4.33e-1)"	"unprognostic (3.54e-2)"	"unprognostic (8.24e-2)"	5.6	5.6	3.3	1.7	3.9	2.3	3.1	4.9	5.3	1.9	7.0	7.0	4.5	11.8	1.6	1.9	5.9	1.3	5.2	16.2	2.5	1.7	10.8	17.2	2.9	2.0	4.5	4.2	2.0	6.0	5.8	1.2	1.3	5.5	3.5	2.0	4.8	9.4	5.6	25.6	5.5	10.4	1.2	4.4	3.7	7.2	49.3	4.9	0.3	1.9	5.4	1.8	2.1	3.3	0.0	0.3	3.8	3.0	0.0	0.1	0.8	2.7	2.7	0.3	22.7	1.0	2.2	14.2	1.3	0.9	0.8	0.5	5.2	5.1	0.0	4.6	2.5	0.0	3.6	0.7	2.0	0.0	0.7	0.0	0.9	4.1	12.2	7.3	0.1	0.0	3.0	9.4	0.9	0.0	0.0	0.1	3.9	3.2	0.0	0.0	3.1	0.2	2.1	1.9	4.2	17.5	0.3	0.0	3.5	2.4	3.3	0.8	0.1	0.0	0.9	0.0	0.3	5.9	3.0	0.1	0.0	3.8	0.0	0.9	0.8	0.9	0.7	0.3	0.7	0.0	0.0	3.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	3.8	0.0	0.4	0.0	0.0	0.8	3.3	3.9	4.9	5.3	2.5	1.7	4.5	4.2	5.5	4.9	3.0	2.7	0.8	1.7	1.8	1.0	2.6	5.1	1.4	3.4	8.7	0.0	1.4	10.0	3.5	97.1	0.7	32.0	0.0	2.4	2.2	1.1	1.6	0.0	20.2	2.1	0.0	1.2	3.1	6.0	174.0	2.3	1.7	0.0	1.0	6.3	5.2	3.8	11.2	3.5	11.0	0.0	0.0	1.0	3.5	2.3	1.6	2.1	1.3	10.9	2.0
PRDX1	"NKEFA, PAGA"	ENSG00000117450	"Peroxiredoxin 1"	Q06830	1	45511036-45523047	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004682, HPA007730"	Approved		Approved	Mitochondria		NA	NA		110000000	Mitochondria		"CAB004682: AB_437046, HPA007730: AB_1855204"	"unprognostic (1.28e-2)"	"unprognostic (4.64e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.95e-2)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (2.47e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.68e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.39e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (2.89e-4)"	43.3	58.2	71.0	43.8	57.4	12.0	75.5	31.6	60.0	46.9	51.1	72.2	42.6	78.5	40.8	75.7	136.1	49.7	46.9	84.2	56.5	73.0	121.7	136.5	52.9	51.0	99.1	51.2	43.0	20.4	34.1	34.3	58.3	87.8	42.2	53.0	48.8	53.5	52.2	78.9	46.9	77.6	52.4	98.3	46.5	52.5	25.7	72.6	29.7	130.1	114.3	91.0	49.1	56.3	44.7	50.3	64.4	64.5	20.4	72.3	58.7	64.7	119.4	49.2	62.6	55.9	47.8	105.4	73.7	76.7	80.1	66.6	59.4	28.1	57.2	77.8	79.1	97.3	67.2	106.9	71.3	79.2	44.0	82.6	43.3	168.6	166.0	24.3	50.0	56.7	41.0	53.3	79.4	18.8	44.0	91.7	68.2	79.1	19.8	79.4	52.0	67.1	48.9	154.3	144.4	125.2	118.3	62.1	75.4	143.8	55.9	65.5	32.9	67.6	183.7	4.7	150.5	49.9	40.5	77.9	32.0	72.4	68.4	98.1	13.8	77.4	109.1	52.9	34.8	18.7	64.4	55.6	18.4	28.5	60.6	37.5	44.7	45.5	37.9	50.3	36.2	28.3	31.0	2.4	20.4	64.5	33.5	72.3	58.7	71.0	57.4	31.6	60.0	56.5	73.0	99.1	51.2	87.8	72.6	485.3	206.7	314.1	835.1	539.4	156.1	25.5	438.2	477.8	340.1	586.2	98.2	1056.6	802.4	878.0	14.3	395.3	667.0	116.8	386.1	1465.8	343.6	670.3	319.6	809.1	1307.1	195.5	167.4	307.6	343.8	26.3	461.7	625.9	551.7	763.8	204.7	292.0	608.7	403.3	386.1	1911.4	290.8	304.0	372.5	90.5	393.1	462.1	932.4	124.6	344.7	1354.4
PRDX2	"MGC4104, NKEFB, PRP, PRX2, PRXII, TDPX1, TSA"	ENSG00000167815	"Peroxiredoxin 2"	P32119	19	12796820-12801859	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase, Peroxidase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	9	"Distal tubular cells: 1115.8;Erythroid cells: 2453.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											CAB008713	Approved					NA	NA		1100000000			"CAB008713: AB_1620974"	"unprognostic (1.12e-1)"	"unprognostic (1.98e-3)"	"unprognostic (8.58e-2)"	"unprognostic (4.40e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.26e-2)"	"unprognostic (9.18e-2)"	"prognostic favorable (5.66e-11)"	"unprognostic (7.01e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.41e-1)"	39.8	95.1	54.7	17.9	55.6	119.1	27.7	52.1	80.8	22.5	39.9	27.8	42.2	53.6	28.1	33.8	49.9	31.5	36.4	142.0	49.2	54.4	44.5	79.4	15.9	22.7	62.2	41.6	40.0	43.0	32.8	49.4	20.9	70.9	30.6	30.8	35.9	42.3	41.5	136.8	44.3	44.9	27.6	27.5	18.1	31.5	13.7	23.5	38.9	36.8	69.9	29.5	31.5	24.6	42.1	24.6	9.5	20.6	23.3	76.8	72.3	45.4	0.1	62.9	81.2	9.1	6.3	46.3	21.1	21.0	28.7	16.4	47.8	11.5	13.4	49.3	20.3	3.4	43.5	39.6	34.2	8.3	57.2	62.7	24.3	64.5	71.3	24.6	0.0	0.1	27.0	15.8	21.6	10.6	37.4	26.6	28.5	51.7	21.1	10.9	82.5	53.5	20.6	46.3	31.6	88.0	53.0	0.0	64.5	38.2	49.3	77.8	61.5	50.0	51.3	16.6	12.0	45.9	34.9	11.7	21.6	18.2	59.8	45.6	25.9	25.2	61.4	20.5	8.1	4.9	2.8	20.6	9.5	53.6	14.3	56.2	42.1	73.5	54.8	24.6	29.2	74.9	58.5	2.7	23.3	15.4	14.4	76.8	72.3	54.7	55.6	52.1	80.8	49.2	54.4	62.2	41.6	70.9	23.5	20.8	27.1	84.8	205.3	196.6	303.0	31.1	249.7	42.8	58.0	265.2	94.2	660.9	1115.8	292.4	2.4	139.3	489.0	2453.0	145.5	433.0	202.0	181.2	47.2	378.1	188.3	203.4	320.3	124.6	63.9	7.6	272.1	62.1	266.6	79.4	252.2	346.8	197.7	212.5	301.9	721.8	254.6	155.2	177.8	4.1	7.0	200.6	425.2	113.3	409.3	193.6
PRDX3	"AOP-1, AOP1, MER5, SP-22"	ENSG00000165672	"Peroxiredoxin 3"	P30048	10	119167703-119178833	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Distal tubular cells: 898.6;Proximal tubular cells: 684.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008656, HPA041488, CAB079909"	Enhanced		Supported	Mitochondria		NA	NA		14000000	Mitochondria		"CAB008656: AB_1620979, CAB079909: AB_2809998, HPA041488: AB_2677508"	"unprognostic (8.29e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.72e-3)"	"unprognostic (4.62e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.48e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.21e-1)"	34.0	100.7	28.8	18.8	28.3	14.4	29.1	16.1	28.9	23.0	27.1	20.7	25.1	28.1	25.5	26.3	30.6	24.8	21.8	55.8	26.7	28.2	78.8	114.8	16.3	20.0	29.9	23.2	19.2	34.1	25.2	24.6	29.9	33.6	27.4	29.6	21.2	40.5	29.3	80.9	10.3	34.6	26.8	24.1	27.4	24.6	14.0	24.6	24.3	48.9	46.1	20.5	25.9	17.9	30.9	65.7	41.4	74.9	20.9	34.2	73.0	54.1	62.1	37.9	43.0	40.1	43.5	23.7	38.9	66.4	59.4	62.5	47.6	54.3	63.6	34.1	45.8	28.3	24.8	62.6	47.0	67.1	62.2	65.9	28.6	27.0	84.2	42.0	53.5	34.7	50.9	30.3	47.4	44.2	42.7	42.9	39.1	35.1	13.3	54.3	21.7	40.4	45.3	35.4	41.3	36.8	43.0	55.1	43.9	100.3	26.0	16.7	24.3	41.3	55.8	51.0	34.2	28.9	64.5	30.2	19.4	29.3	27.7	50.4	20.8	30.3	51.0	30.5	79.5	17.2	19.5	74.9	40.8	20.3	61.8	25.9	30.9	27.1	24.5	65.7	24.3	28.3	25.2	41.4	20.9	53.2	36.8	34.2	73.0	28.8	28.3	16.1	28.9	26.7	28.2	29.9	23.2	33.6	24.6	44.7	64.4	72.5	95.3	62.0	25.6	212.3	122.3	104.4	39.8	139.6	9.8	296.9	898.6	109.2	4.2	70.9	99.7	70.0	65.9	187.6	95.6	106.7	51.9	340.4	218.6	38.1	106.5	71.2	159.0	8.6	71.7	113.7	126.5	146.1	117.2	58.7	65.7	98.2	95.1	684.3	19.1	71.1	104.2	10.0	22.8	45.9	129.6	54.3	181.8	109.3
PRDX5	"ACR1, AOEB166, B166, MGC117264, MGC142283, MGC142285, PLP, PMP20, PRDX6, PRXV, SBBI10"	ENSG00000126432	"Peroxiredoxin 5"	P30044	11	64318088-64321811	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase, Peroxidase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008661, HPA037915, HPA037916"	Enhanced		Supported	Mitochondria		NA	NA		19000000	Mitochondria		"CAB008661: AB_1620988, HPA037915: AB_2675735, HPA037916: AB_2675736"	"unprognostic (2.75e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.43e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.08e-3)"	"unprognostic (3.11e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.20e-1)"	"prognostic favorable (1.24e-5)"	"unprognostic (8.19e-2)"	"unprognostic (2.30e-1)"	"unprognostic (9.63e-2)"	"unprognostic (5.03e-2)"	28.7	69.7	70.3	38.6	60.3	57.0	35.5	69.3	73.9	47.2	79.3	31.9	49.0	49.5	26.6	54.8	69.6	94.9	44.8	102.4	56.7	74.2	57.3	54.2	50.3	25.0	68.6	70.2	42.2	72.0	36.0	53.7	49.1	71.4	30.7	71.2	33.9	77.5	62.6	104.7	27.0	51.2	30.9	44.1	27.3	64.5	35.0	29.3	25.1	82.0	64.8	33.5	34.4	50.4	55.2	69.2	115.0	66.9	48.4	40.5	75.3	26.3	53.8	32.6	53.9	35.1	52.9	37.7	33.0	52.9	24.3	30.3	39.1	54.1	38.6	57.8	52.7	87.4	60.3	30.4	70.1	15.4	53.6	24.0	39.0	84.6	44.5	72.1	14.7	33.3	53.6	91.6	40.7	41.3	47.5	36.8	45.9	21.9	91.9	34.1	66.8	25.7	64.1	49.3	41.7	68.8	24.8	33.5	136.5	90.8	52.3	27.6	52.6	27.6	61.3	94.1	32.6	44.9	33.6	35.5	34.7	32.3	40.1	14.5	47.0	56.0	45.5	42.0	29.8	27.0	79.8	66.9	85.4	37.7	59.6	32.7	53.8	35.0	30.8	52.4	55.2	34.8	35.0	115.0	48.4	52.5	69.2	40.5	75.3	70.3	60.3	69.3	73.9	56.7	74.2	68.6	70.2	71.4	29.3	247.1	407.2	232.2	603.5	290.1	156.4	523.8	356.7	1310.3	342.4	427.5	66.8	1002.3	1366.1	644.2	57.6	187.4	757.5	163.5	919.1	972.3	308.0	330.5	103.7	331.1	418.0	87.4	770.7	194.0	207.8	207.7	258.3	234.8	413.3	423.8	875.2	180.0	1093.8	547.1	213.2	1094.9	109.1	194.1	199.4	113.7	345.0	225.2	818.7	191.8	959.8	988.5
PRDX6	"1-Cys, aiPLA2, AOP2, KIAA0106, MGC46173, NSGPx, p29, PRX"	ENSG00000117592	"Peroxiredoxin 6"	P30041	1	173477266-173488807	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Antioxidant, Hydrolase, Multifunctional enzyme, Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA006983, CAB008663"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		180000000	"Plasma membrane, Cytosol"		"CAB008663: AB_1620994, HPA006983: AB_1079595"	"unprognostic (9.92e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (1.23e-5)"	"unprognostic (5.71e-3)"	"unprognostic (2.80e-2)"	"unprognostic (5.27e-3)"	"unprognostic (3.96e-3)"	"unprognostic (3.19e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (9.51e-4)"	"unprognostic (2.50e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.73e-3)"	80.0	42.1	32.8	30.8	38.9	21.8	106.3	19.8	32.8	27.2	46.7	37.4	35.8	12.1	30.8	54.1	39.9	40.2	22.3	70.5	29.0	23.9	45.9	116.1	29.2	37.5	34.0	28.2	31.5	39.3	63.9	19.1	36.9	30.3	40.0	56.0	21.3	22.6	35.4	128.0	25.7	20.2	40.5	19.7	23.1	33.2	44.9	24.1	17.4	46.9	68.6	25.7	36.5	46.2	17.2	37.9	14.3	23.9	12.0	25.0	30.6	52.1	16.0	26.6	29.5	103.2	50.5	22.5	106.5	36.3	44.5	31.6	30.2	35.1	33.9	34.1	87.2	16.4	30.5	34.8	34.3	36.2	29.8	32.1	22.5	27.4	34.1	58.2	23.5	7.4	41.8	34.8	24.4	34.2	28.0	43.6	14.2	50.0	7.0	50.5	10.7	15.9	31.0	58.5	28.7	99.6	19.1	30.8	34.6	66.6	11.9	12.4	23.0	36.7	43.2	24.4	40.0	36.5	33.2	29.3	17.3	19.9	26.2	28.9	10.6	15.7	27.9	20.8	20.5	15.8	13.9	23.9	12.9	17.0	20.6	18.9	17.2	17.6	21.1	29.3	13.6	23.2	25.0	14.3	12.0	17.5	37.9	20.4	30.6	32.8	38.9	19.8	32.8	29.0	23.9	34.0	28.2	30.3	24.1	163.8	131.5	140.0	350.9	209.2	31.5	477.5	249.7	195.4	161.5	263.5	27.5	589.1	729.5	163.2	193.0	183.6	264.7	256.9	175.5	640.5	290.3	337.6	341.6	875.0	302.1	42.9	136.4	174.3	152.8	441.3	315.2	140.2	173.7	230.0	253.4	390.8	159.2	306.9	391.7	634.8	41.0	181.1	254.2	113.1	58.3	231.0	805.7	161.9	278.6	280.8
